The Manufacturers Life Insurance Company Invests $9.44 Million in Avantor, Inc. $AVTR

The Manufacturers Life Insurance Company bought a new position in Avantor, Inc. (NYSE:AVTRFree Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 953,968 shares of the company’s stock, valued at approximately $9,444,000.

A number of other hedge funds have also added to or reduced their stakes in the stock. BlackRock Inc. bought a new position in shares of Avantor in the second quarter valued at approximately $695,784,000. Wellington Management Group LLP bought a new stake in Avantor during the 4th quarter worth approximately $268,584,000. Engine Capital Management LP lifted its stake in Avantor by 65.8% in the 1st quarter. Engine Capital Management LP now owns 19,780,830 shares of the company’s stock worth $155,082,000 after purchasing an additional 7,853,018 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC purchased a new stake in Avantor in the 2nd quarter worth approximately $195,386,000. Finally, Morgan Stanley boosted its holdings in Avantor by 179.4% in the 4th quarter. Morgan Stanley now owns 17,468,418 shares of the company’s stock valued at $200,188,000 after purchasing an additional 11,216,565 shares during the period. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Avantor Stock Down 0.1%

AVTR opened at $14.60 on Friday. The business’s fifty day simple moving average is $12.12 and its 200 day simple moving average is $9.77. Avantor, Inc. has a 52 week low of $7.26 and a 52 week high of $15.93. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.65. The stock has a market cap of $9.87 billion, a PE ratio of -17.38, a P/E/G ratio of 11.00 and a beta of 0.89.

Avantor (NYSE:AVTRGet Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The company reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.19 by $0.02. Avantor had a positive return on equity of 9.92% and a negative net margin of 8.81%.The firm had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.61 billion. During the same quarter in the previous year, the company posted $0.24 earnings per share. The company’s revenue was up .5% compared to the same quarter last year. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. As a group, research analysts expect that Avantor, Inc. will post 0.81 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently commented on AVTR. Citigroup boosted their target price on Avantor from $9.00 to $11.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 8th. Morgan Stanley raised their price target on Avantor from $10.00 to $14.00 and gave the company an “equal weight” rating in a report on Thursday, July 30th. Evercore set a $10.50 price target on Avantor in a research report on Monday, July 6th. Wolfe Research raised Avantor from a “strong sell” rating to a “hold” rating in a report on Thursday, July 30th. Finally, Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $13.00 price objective on shares of Avantor in a research report on Thursday, July 30th. Two analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $12.00.

Get Our Latest Stock Report on Avantor

Avantor Profile

(Free Report)

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.

Read More

Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTRFree Report).

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.